Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2017-04-25 2017-04-25
Drug Identification Number 02267470 02267470
Brand name TEVA-BISOPROLOL TEVA-BISOPROLOL
Common or Proper name BISOPROLOL FUMARATE BISOPROLOL FUMARATE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients BISOPROLOL FUMARATE BISOPROLOL FUMARATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-01-15 2017-01-15
Actual start date
Estimated end date 2017-03-10 2017-03-10
Actual end date 2017-03-10 2017-03-10
Shortage status Resolved Resolved
Company comments
Health Canada comments